减少辐射暴露区域,通过诱导DNA损伤和保护淋巴细胞,增强了抗瘤作用
Huiqin Chen1,2,3, Yuan Li1,4, Qiaofeng Shen2
1Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325000, China.
Molecular medicine (Cambridge, Mass.)
|December 30, 2024
概括
减少瘤区域放射治疗 (RTRT) 有效地杀死癌细胞,同时保留免疫细胞并最大限度地减少组织损伤. 这种方法提高了生存率,并为将放射治疗与免疫治疗结合起来提供了潜力.
科学领域:
- 辐射瘤学 辐射瘤学
- 免疫治疗是一种免疫疗法.
- 癌症生物学 癌症生物学
背景情况:
- 针对缺氧瘤区域的立体体辐射疗法 (SBRT) 可以通过免疫反应提高放射治疗的疗效.
- 减少辐射目标体积可能会改善抗瘤效果,并最大限度地减少正常组织损伤.
- 这项研究评估了减少瘤区域放射治疗 (RTRT) 以控制瘤和保护免疫力.
研究的目的:
- 评估与传统放射治疗 (CNRT) 相比,RTRT的抗瘤疗效.
- 探索瘤控制与免疫保护之间的关系.
- 阐明RTRT效应背后的分子机制.
主要方法:
- 在小鼠乳腺癌模型中RTRT和CNRT的比较,评估瘤生长,转移和存活率.
- 评估周围瘤组织损伤和免疫微环境.
- 在实验室中评估状细胞成熟和DNA损伤的辐射瘤细胞.
主要成果:
- 无论是RTRT还是CNRT都抑制了原发性瘤的生长;RTRT显著延长了生存时间和增加了腹腔效应.
- RTRT保存了周围瘤淋巴细胞,并减少了周围组织和循环淋巴细胞的损伤.
- 在体外,RTRT诱导了DNA损伤,激活了cGAS-STING通路,并释放了DAMP,放大了抗瘤免疫反应.
结论:
- 在RTRT中缩小辐射目标体积可以杀死瘤细胞,减少组织损伤,并保护淋巴细胞.
- RTRT提高了放射治疗的安全性和疗效,提供了与免疫治疗结合的机会.
相关概念视频
01:27Tumor Immunotherapy
394
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
394
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K